Clinical Trial Update: Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating administering Nirsevimab to infants, with or without maternal RSV vaccination, to prevent RSV infection. The study status is not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Nirsevimab (nirsevimab)

Snippet

Sponsor: Centre Hospitalier Annecy Genevois | Conditions: RSV Immunization | Phase 3 | Status: NOT_YET_RECRUITING